2016 Review "Multiple Sclerosis Industry" : Market Analysis, Trend, Share, Growth, Forecast 2019
Description-
Executive
Summary
The
global Multiple
Sclerosis
market is undergoing drastic change since the last few years. The
rising diagnosis and treatment rate coupled with growing investment
in research and development has played a key role in the determining
the growth dynamics of the global Multiple Sclerosis (MS) market.
Currently,
MS is known to affect an estimated 2.5 million people around the
world with around 5000 new cases emerging each year. Since there is
no particular cure or treatment for multiple sclerosis, the market is
currently dominated by few drugs and medication like Copaxone,
Avonex, Betaseron and Extavia which delay or reduce the progression
of multiple sclerosis in individuals.
To
Browse a Report Detail with TOC @
http://www.researchmoz.us/global-multiple-sclerosis-market-trends-and-opportunities-2013-18-report.html
Until
the last year, MS market was led by self injectables drugs such as
Capaxone and Avonex that caused side effects like swelling, anxiety,
redness and difficult breathing. To address these shortcomings and
side effects, pharmaceutical companies developed oral drugs that are
considered safe and effective. With the beginning of 2013, oral drugs
such as Gilenya and Aubagio witnessed rapid demand due to their
higher efficacy and better results. In addition, there are many drugs
down the pipeline that would change the dynamics and growth of the
multiple sclerosis market in future. For instance, Teva hopes its
Copaxone successor, laquinimod, may help it preserve some market
share when Copaxone loses patent protection.
Scope
of the Report
The
report titled “Global Multiple Sclerosis Market: Trends &
Opportunities (2013-18)“ provide an insight into the market
dynamics and various trends and opportunities associated with the
global multiple sclerosis market. The report analyzes the various
causes and symptoms related to the prevalence of MS in patients.
Further, the report analyzes the global market sizing and growth of
multiple sclerosis in terms of revenue, number of patients and sales
of effective drugs. Also, the domestic market of United States which
is the largest contributor to the global multiple sclerosis market
has been assessed. The report concludes with a brief discussion of
major factors driving the global multiple sclerosis market and
profiles major players like Teva, Biogen Idec, Merck KGaA, Bayer and
Novartis.
Geographical
Coverage
- Global
- United States
Company
Coverage
- Teva
- Biogen Idec
- Merck KGaA
- Bayer
- Novartis
Table
of Content
1.
Executive Summary
2.
Global Multiple Sclerosis Market: An Overview
3.
Global Multiple Sclerosis Market: An Analysis
3.1.
Global Multiple Sclerosis Market: Sizing & Growth (Actual &
Forecast)
3.2.
Number of Multiple Sclerosis Patients Worldwide
3.3.
Global Multiple Sclerosis Market: Market Share Analysis
3.3.1.
Market Share: By Major Players
3.3.2.
United States Vs Rest of the World
3.3.3.
Multiple Sclerosis Market: Competitors Share Shift
3.4.
Average Revenue per Patient by Region
4.
Multiple Sclerosis Market: Country Analysis
4.1.
United States: Multiple Sclerosis Market
4.1.1.
United States Multiple Sclerosis Market: Sizing and Growth (Actual &
Forecast)
4.1.2.
Number of MS Patients in the United States
5.
Growth Drivers of Multiple Sclerosis Market
6.
Company Profiles: Multiple Sclerosis Market
6.1.
Teva
6.1.1.
Business Description
6.1.2.
Financial Analysis
6.1.3.
Business Strategies
6.2.
Biogen Idec
6.2.1.
Business Description
6.2.2.
Financial Analysis
6.2.3.
Business Strategies
6.3.
Merck KGaA
6.3.1.
Business Description
6.3.2.
Financial Analysis
6.3.3.
Business Strategies
6.4.
Bayer
6.4.1.
Business Description
6.4.2.
Financial Analysis
6.4.3.
Business Strategies
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Website: http://www.researchmoz.us
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Website: http://www.researchmoz.us
Comments
Post a Comment